|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 970 |
FusionGeneSummary for AEBP2_PRLR |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AEBP2_PRLR | Fusion gene ID: 970 | Hgene | Tgene | Gene symbol | AEBP2 | PRLR | Gene ID | 121536 | 5618 |
| Gene name | AE binding protein 2 | prolactin receptor | |
| Synonyms | - | HPRL|MFAB|RI-PRLR|hPRLrI | |
| Cytomap | 12p12.3 | 5p13.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | zinc finger protein AEBP2AE(adipocyte enhancer)-binding protein 2adipocyte enhancer-binding protein 2 | prolactin receptorhPRL receptorsecreted prolactin binding protein | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q6ZN18 | P16471 | |
| Ensembl transtripts involved in fusion gene | ENST00000541908, ENST00000398864, ENST00000266508, ENST00000360995, | ENST00000342362, ENST00000382002, ENST00000231423, ENST00000513753, ENST00000397391, ENST00000348262, ENST00000542609, ENST00000310101, ENST00000511486, ENST00000509934, | |
| Fusion gene scores | * DoF score | 8 X 6 X 7=336 | 6 X 5 X 4=120 |
| # samples | 9 | 6 | |
| ** MAII score | log2(9/336*10)=-1.90046432644909 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(6/120*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: AEBP2 [Title/Abstract] AND PRLR [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | PRLR | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity | 10585417 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SKCM | TCGA-D3-A3CC-06A | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000541908 | ENST00000342362 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000541908 | ENST00000382002 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000231423 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000513753 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000397391 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000348262 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000542609 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000310101 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000511486 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000541908 | ENST00000509934 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000398864 | ENST00000342362 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000398864 | ENST00000382002 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000231423 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000513753 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000397391 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000348262 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000542609 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000310101 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000511486 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000398864 | ENST00000509934 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000266508 | ENST00000342362 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000266508 | ENST00000382002 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000231423 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000513753 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000397391 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000348262 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000542609 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000310101 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000511486 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000266508 | ENST00000509934 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000360995 | ENST00000342362 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-5UTR | ENST00000360995 | ENST00000382002 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000231423 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000513753 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000397391 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000348262 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000542609 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000310101 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000511486 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
| 5CDS-intron | ENST00000360995 | ENST00000509934 | AEBP2 | chr12 | 19646920 | + | PRLR | chr5 | 35118224 | - |
Top |
FusionProtFeatures for AEBP2_PRLR |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AEBP2 | PRLR |
| DNA-binding transcriptional repressor. May interact withand stimulate the activity of the PRC2 complex, which methylates'Lys-9' and 'Lys-27' residues of histone H3.{ECO:0000269|PubMed:15225548}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for AEBP2_PRLR |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for AEBP2_PRLR |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| AEBP2 | LDOC1, RALYL, EED, SUZ12, RBBP4, HIST1H1A, HIST1H1C, SETD8, ELAVL1, APP, JMJD6, FBXW11, HMBOX1, JARID2, EZH2, RBBP7, ATXN3, KBTBD7, BTRC, THAP1 | PRLR | PPIA, SOCS3, TEC, VAV1, SOCS2, JAK2, PTPN11, GTF3A, FBXW11, CREBBP, PRLR, STAT5B, BTRC |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AEBP2_PRLR |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Tgene | PRLR | P16471 | DB01185 | Fluoxymesterone | Prolactin receptor | small molecule | approved|illicit |
| Tgene | PRLR | P16471 | DB00052 | Somatotropin | Prolactin receptor | biotech | approved|investigational |
Top |
RelatedDiseases for AEBP2_PRLR |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | PRLR | C0024667 | Animal Mammary Neoplasms | 2 | CTD_human |
| Tgene | PRLR | C0000786 | Spontaneous abortion | 1 | CTD_human |
| Tgene | PRLR | C0004352 | Autistic Disorder | 1 | CTD_human |
| Tgene | PRLR | C0014175 | Endometriosis | 1 | CTD_human |
| Tgene | PRLR | C0020514 | Hyperprolactinemia | 1 | HPO;ORPHANET;UNIPROT |
| Tgene | PRLR | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | PRLR | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Tgene | PRLR | C3809918 | MULTIPLE FIBROADENOMAS OF THE BREAST | 1 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|